Top Industry Leaders in the Rabies Treatment Market
Latest Rabies Treatment Companies Update
Sanofi Pasteur's rabies monoclonal antibody program: In October 2023, Sanofi Pasteur announced the initiation of Phase 1 clinical trials for its novel rabies monoclonal antibody program. This potentially game-changing development aims to offer a long-acting, non-vaccine alternative for post-exposure prophylaxis (PEP).
New rabies immunoglobulin (RIG) formulations: Bavarian Nordic received EU approval for its Rabipur® P intramuscular/subcutaneous rabies immunoglobulin formulation in August 2023. This offers healthcare professionals new options for administering RIG, potentially improving accessibility and convenience.
List of Rabies Treatment Key Companies in the Market
- Sanofi (France)
- Merck & Co. Inc.
- CSC Pharmaceuticals International
- Pfizer (U.S.)
- VBI Vaccines Inc. (U.S.)
- Taj Pharmaceuticals Limited (India)
- Bio Med Pvt. Ltd.
- Bavarian Nordic(U.S.)
- Solvay(U.S.)
- Informa plc.(U.S.)